The French Ministry of Solidarity and Health constantly announces the new experiments initiated under Article 51 of the Social Security Financing Act. These experiments are focused on various topics concerning medical technologies and the organization of care. At the end of July, three new experiments related to the system of care for people with disabilities, families with overweight children, and homeless drug users were announced.
Article 51 of the Social Security Financing Act allows for the financing of innovative technologies and organizational schemes in the health sector. In order to receive financing via this framework, the experiments proposed must improve healthcare access, system efficiency, the relevance of prescription, and patient pathway. With this approach, the experimentations can bypass one or more of the 63 regulations of social security financing laws, if it is on the coordination of medical pathway, relevance and quality of health, social or medico-social services, structuration of ambulatory cares and healthcare access.
At the end of July, new experiments under Article 51 of the Social Security Financing Act were announced by the Ministry of Solidarity and Health:
- “FACILISOINS - Health package for people with disabilities in an establishment or medico-social service” with 1,5 years of experiment duration (details related to the total financing are not available);
- “PROXOB - interdisciplinary care in home settings for families with overweight children” with five years of experiment duration and total financing of €1,882,965;
- “ARGOS 2 - a system of care for homeless drug users” with three years of experiment duration and total financing of €2,694,981 (package of €121 per person per day).
The full details in French can be found here.
This news is just one of about 300 market access news collected by our team in the subscription services "HTA Alerts" and "Reimbursement Alerts" every two weeks from more than 80 organizations. Access our paid subscription services to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news). First EU issues of both newsletters are available for download free-of-charge.
Not ready for a subscription service? Subscribe to our free-of-charge newsletter delivered every second week to get updates about key reimbursement developments in Europe (10-12 news every two weeks).